Genes & Diseases
Scope & Guideline
Exploring the molecular pathways of health and illness.
Introduction
Aims and Scopes
- Molecular Genetics and Disease Mechanisms:
Research exploring the genetic basis of diseases, including the identification of mutations, polymorphisms, and their roles in disease progression. - Transcriptional and Epigenetic Regulation:
Studies on how transcriptional control and epigenetic modifications influence gene expression in the context of various diseases. - Cancer Biology and Therapeutics:
Investigations into the molecular mechanisms of cancer, including tumor microenvironment interactions, signaling pathways, and therapeutic targets. - Immunology and Autoimmunity:
Research on immune responses in disease states, including the role of immune checkpoints, inflammatory pathways, and autoimmune conditions. - Stem Cell Biology and Regenerative Medicine:
Exploration of stem cell mechanisms, differentiation, and their therapeutic applications in disease treatment and tissue regeneration. - Metabolism and Disease:
Studies on metabolic pathways and their alterations in diseases such as obesity, diabetes, and cancer, focusing on therapeutic implications. - Neurobiology and Neurodegenerative Diseases:
Research into the genetic and molecular underpinnings of neurodegenerative diseases, including Alzheimer's and Parkinson's disease. - Infectious Diseases and Host Response:
Investigations into the genetic factors affecting susceptibility to infectious diseases and the host's immune response mechanisms.
Trending and Emerging
- Multi-Omics Approaches:
There is a growing emphasis on integrating genomic, transcriptomic, proteomic, and metabolomic data to provide a comprehensive understanding of disease mechanisms and therapeutic targets. - Precision Medicine and Personalized Therapies:
Research focused on tailoring treatment strategies based on genetic and molecular profiling of patients is gaining traction, reflecting the shift towards individualized healthcare. - Ferroptosis and Regulated Cell Death:
Ferroptosis, a form of regulated cell death, is emerging as a significant area of research, particularly in its implications for cancer therapy and neurodegenerative diseases. - Immunotherapy and Cancer Microenvironment:
Studies exploring the interactions between cancer cells and the immune microenvironment, including the role of immune checkpoints and tumor-infiltrating lymphocytes, are increasingly prominent. - Gene Editing Technologies:
The application and implications of CRISPR and other gene editing technologies in treating genetic disorders and cancers are trending, highlighting their potential for future therapies. - Role of Non-Coding RNAs in Disease:
Research into the functions and mechanisms of long non-coding RNAs (lncRNAs) and circular RNAs in various diseases is on the rise, emphasizing their potential as biomarkers and therapeutic targets. - Microbiome and Human Health:
Explorations of the relationship between the microbiome and various diseases, including metabolic and autoimmune conditions, are becoming a significant focus. - Neuroinflammation and Neurodegeneration:
Research on the mechanisms of neuroinflammation and its role in neurodegenerative diseases is gaining importance, reflecting a broader understanding of brain health.
Declining or Waning
- Traditional Genetic Association Studies:
While genetic association studies remain important, there has been a noticeable shift toward more integrative approaches that combine genomics with other omics data, leading to a decline in standalone genetic association studies. - Basic Mechanistic Studies Without Clinical Relevance:
Research that focuses solely on basic mechanisms without a clear clinical application or relevance is becoming less frequent, as the journal prioritizes studies with translational potential. - Single-Factor Analyses in Complex Diseases:
There is a decrease in studies that analyze single genetic or molecular factors in complex diseases, with a growing preference for multi-factorial and systems biology approaches. - Historical Reviews on Established Diseases:
Reviews focusing on well-established diseases without new insights or perspectives are waning, as the journal seeks fresh, innovative content that addresses current research gaps.
Similar Journals
CELLULAR SIGNALLING
Connecting Discoveries in Molecular BiologyCELLULAR SIGNALLING, published by Elsevier Science Inc, is a premier journal within the realm of Cell Biology, boasting an impressive Q2 category ranking as of 2023. With an ISSN of 0898-6568 and an E-ISSN of 1873-3913, the journal has established itself as a critical platform for advancing the understanding of cellular mechanisms and signal transduction pathways since its inception in 1989. Covering a vast array of topics in Biochemistry, Genetics, and Molecular Biology, it ranks notably at 87 out of 285 in the Scopus list, placing it in the 69th percentile among its peers. The journal serves as an invaluable resource for researchers, professionals, and students seeking high-quality, impactful studies that drive forward the field of cellular biology. While it operates under traditional subscription access, its highlights include rigorous peer-reviewed articles, reviews, and insights that continue to shape current scientific discourse.
DNA AND CELL BIOLOGY
Unraveling the Mysteries of DNA and Cell DynamicsDNA AND CELL BIOLOGY, published by Mary Ann Liebert, Inc, is a distinguished journal in the realms of cell biology, genetics, and molecular biology, holding a notable position in its Q3 and Q2 quartile rankings across multiple academic categories as of 2023. With an ISSN of 1044-5498 and an E-ISSN of 1557-7430, this journal has been a pivotal platform for the dissemination of cutting-edge research since its inception in 1990, extending its coverage through 2024. Situated in the United States, the journal offers high-quality peer-reviewed articles, exploring significant advancements in biological sciences while fostering interdisciplinary collaborations within the research community. Though it currently does not offer open access, subscribed institutions and individual readers benefit from its rich repository of knowledge. The journal's rigorous standards and impactful content make it an essential resource for researchers, professionals, and students alike, aiming to stay at the forefront of discoveries influencing DNA and cellular dynamics.
BIOCELL
Innovative Insights into Cellular MechanismsBIOCELL is a distinguished peer-reviewed journal dedicated to the field of Cell Biology, published by TECH SCIENCE PRESS. Since its inception in 1995, the journal has been at the forefront of disseminating innovative research, with converged publication years extending from 1995 to 2013 and from 2015 to 2024. Although it currently holds a Q4 ranking in the Cell Biology category according to the 2023 category quartiles, BIOCELL aims to foster advancements by providing a platform for researchers, professionals, and students to share their findings in biochemistry, genetics, and molecular biology. The journal is available in both print (ISSN: 0327-9545) and digital formats (E-ISSN: 1667-5746) and seeks to attract contributions that enhance scholarly dialogue and understandings of cellular mechanisms and innovations. With a commitment to quality research and critical discourse, BIOCELL plays an important role in nurturing the scientific community within Argentina and beyond, offering vital insights that contribute to the advancement of the life sciences.
Cell and Bioscience
Empowering Knowledge Sharing in Molecular BiologyCell and Bioscience is a prestigious open-access journal published by BMC that has been at the forefront of biochemistry, genetics, and molecular biology since its inception in 2011. With an impressive impact factor, this journal has established itself as a vital resource for researchers and professionals in these rapidly advancing fields, reflecting its high ranking of #29 out of 221 in the Scopus classification and placing it in the 87th percentile. Based in the United Kingdom, Cell and Bioscience aims to foster innovation and dissemination of research findings addressing critical biological questions through rigorous peer-reviewed articles and inter-disciplinary approaches. The journal's open-access model ensures unrestricted access to transformative research, promoting collaboration and knowledge sharing among academics, students, and practitioners worldwide. With a commitment to maintaining excellence in the field, Cell and Bioscience provides an essential platform for those looking to contribute to the evolving landscape of biosciences.
FEBS Journal
Pioneering Discoveries in Life SciencesFEBS Journal is a prestigious, peer-reviewed publication dedicated to advancing the field of biochemistry, cell biology, and molecular biology. Published by WILEY in the United Kingdom, this journal boasts an impressive impact factor and ranks in the top quartile (Q1) across multiple relevant categories, including Biochemistry, Cell Biology, and Molecular Biology, reflecting its significant contribution to scientific research. With an ISSN of 1742-464X and an E-ISSN of 1742-4658, the FEBS Journal publishes original research and comprehensive reviews that push the boundaries of knowledge and innovation in the biosciences. As a vital resource for researchers, professionals, and students alike, the journal offers Open Access options, ensuring that cutting-edge discoveries are accessible to a broad audience. With a publication history converging from 2005 to the present and a robust emphasis on high-quality scholarly work, the FEBS Journal remains an essential platform for the dissemination of significant findings and advancements in the life sciences.
Cell Communication and Signaling
Illuminating the Pathways of Cellular DialogueCell Communication and Signaling is a premier peer-reviewed journal published by BMC that has made significant contributions to the fields of biochemistry, cell biology, and molecular biology since its establishment in 2003. As an open access journal, it offers unrestricted access to high-quality research, fostering collaboration and innovation among scientists around the globe. The journal is distinguished by its Q1 ranking in all three relevant categories for 2023, underscoring its critical role in advancing the understanding of cellular communication mechanisms and signaling pathways. Positioned within the United Kingdom, Cell Communication and Signaling has been an invaluable resource for researchers, professionals, and students alike, ensuring that the latest findings are accessible to a diverse range of audiences. With an impressive Scopus ranking—placing it in the top percentiles within its subject areas—this journal continues to set the standard for excellence in the pursuit of understanding complex cellular interactions.
Cell Reports
Pioneering Open Access for Tomorrow's InnovationsCell Reports is a prestigious open-access journal published by CELL PRESS that has firmly established itself as a leading voice in the fields of Biochemistry, Genetics, and Molecular Biology. Since its inception in 2012, the journal has provided an innovative platform for rapid dissemination of cutting-edge research, ensuring that high-quality findings are accessible to a global audience. With an impressive impact factor and ranking within the top 10% in its category, as reflected by its Q1 ranking in Scopus, Cell Reports serves a vital role in advancing scientific knowledge and fostering collaboration among researchers. The journal's commitment to the open-access model not only enhances visibility but also encourages the sharing of critical advancements in molecular biology. Situated in the Netherlands, its contributions are recognized worldwide, making Cell Reports an indispensable resource for scientists aiming to stay at the forefront of their fields and facilitate breakthroughs that may shape the future of biomedicine.
CELL RESEARCH
Illuminating the Pathways of Life SciencesCELL RESEARCH is a premier peer-reviewed journal dedicated to advancing the field of cell biology and molecular biology, published by SpringerNature. With an impressive impact factor and consistently ranking in the Q1 quartile for both cell biology and molecular biology, this journal serves as a pivotal resource for researchers, professionals, and students seeking to explore the latest discoveries and advancements in cellular mechanisms and their implications for health and disease. Since its inception in 1996, CELL RESEARCH has cultivated a distinguished reputation, currently boasting ranks in the top percentile of Scopus categories, reaffirming its influence and relevance to the scientific community. Although it is not an Open Access journal, its rigorous selection process ensures the publication of high-quality articles that contribute significantly to our understanding of life sciences. For those deeply engaged in the realms of biochemistry, genetics, and molecular biology, CELL RESEARCH is an essential conduit of innovative research and critical insights.
Cell Discovery
Exploring the Depths of Biochemistry and GeneticsCell Discovery, published by SPRINGERNATURE, is a premier open access journal in the dynamic fields of Biochemistry, Cell Biology, Genetics, and Molecular Biology. Since its inception in 2015, this journal has established itself as a key platform for disseminating high-impact research and is recognized with a Q1 ranking across all its core categories for the year 2023. With its remarkable Scopus rankings—7th in Genetics, 9th in Biochemistry, 13th in Molecular Biology, and 15th in Cell Biology—Cell Discovery positions itself among the elite journals in life sciences, showcasing the most innovative breakthroughs and comprehensive reviews. Based in the United Kingdom, this journal operates under an open access model, ensuring that groundbreaking discoveries are readily available to researchers, professionals, and students around the globe. With a commitment to advancing scientific knowledge, Cell Discovery welcomes contributions that push the frontiers of our understanding in cellular and genetic sciences.
FASEB BioAdvances
Elevating Understanding of Biological Processes GloballyFASEB BioAdvances, published by WILEY, is an esteemed open-access journal dedicated to advancing the fields of biochemistry, molecular biology, and physiology. Since its inception in 2019, the journal has rapidly established a significant presence within the academic community, boasting an impressive impact factor reflective of its Q2 and Q3 standings across various categories, including Biochemistry, Genetics and Molecular Biology, Cancer Research, Molecular Medicine, and Physiology. The journal aims to disseminate high-quality research and innovative findings to enhance the understanding of biological processes, making it a vital resource for researchers, professionals, and students alike. With its commitment to open access, FASEB BioAdvances ensures that groundbreaking research is available to a global audience, facilitating collaboration and exploration in these rapidly evolving scientific domains.